CSPIA
RDY icon

Cary Street Partners Investment Advisory’s Dr. Reddy's Laboratories RDY Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,575
Closed -$21.1K – 1537
2023
Q3 		$21.1K Hold
1,575
– – ﹤0.01% 1101
2023
Q2 		$19.9K Buy
+1,575
New +$18.4K ﹤0.01% 1049

Other funds holding RDY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Cary Street Partners Investment Advisory's RDY Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Dr. Reddy's Laboratories (RDY) in Q4 2023, closing a stake of 1,575 shares — an estimated $21.1K sold.

Cary Street Partners Investment Advisory first reported a position in RDY in Q2 2023 and held it in 2 quarters. The position peaked at $21.1K in Q3 2023. 224 funds tracked by Wall St. Rank hold RDY as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Dr. Reddy's Laboratories position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 1,575 Dr. Reddy's Laboratories shares in Q4 2023, an estimated $21.1K.
  • Cary Street Partners Investment Advisory first reported a position in Dr. Reddy's Laboratories in Q2 2023 and held it in 2 quarters.
  • Cary Street Partners Investment Advisory's Dr. Reddy's Laboratories position peaked at $21.1K in Q3 2023.
  • 224 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.